Selected publications

  • Garitano-Trojaola A, José-Enériz ES, Ezponda T, Unfried JP, Carrasco-León A, Razquin N, Barriocanal M, Vilas-Zornoza A, Sangro B, Segura V, Prósper F, Fortes P, Agirre X. Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells. Oncotarget. 2018 Feb 5;9(16):12842-12852.

  • Barriocanal M, Fortes P. Long Non-coding RNAs in Hepatitis C Virus-Infected Cells. Front Microbiol. 2017 Sep 28;8:1833. doi: 10.3389/fmicb.2017.01833. eCollection 2017. Review.

  • Sobrevals L, Enguita M, Quiroga J, Prieto J, Fortes P. Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in Rats. PLoS One. 2016 Sep 22;11(9):e0162955.

  • Di Scala M, Gil-Fariña I, Olagüe C, Vales A, Sobrevals L, Fortes P, Corbacho D, González-Aseguinolaza G. Identification of IFN-γ-producing T cells as the main mediators of the side effects associated to mouse interleukin-15 sustained exposure. Oncotarget. 2016 Aug 2;7(31):49008-49026.

  • Carnero E, Barriocanal M, Prior C, Pablo Unfried J, Segura V, Guruceaga E, Enguita M, Smerdou C, Gastaminza P, Fortes P. Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication. EMBO Rep. 2016 Jul;17(7):1013-28.

  • Kambara H, Niazi F, Kostadinova L, Moonka DK, Siegel CT, Post AB, Carnero E, Barriocanal M, Fortes P, Anthony DD, Valadkhan S. Negative regulation of the interferon response by an interferon-induced long non-coding RNA. Nucleic Acids Res. 2014;42(16):10668-80.

  • Enguita-Germán M, Fortes P. Targeting the insulin-like growth factor pathway in hepatocellular carcinoma. World J Hepatol. 2014 Oct 27;6(10):716-37. Review.

  • Alzuguren P, Hervas-Stubbs S, Gonzalez-Aseguinolaza G, Poutou J, Fortes P, Mancheno U, Bunuales M, Olagüe C, Razquin N, Van Rooijen N, Enguita M, Hernandez-Alcoceba R. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver. Liver Int. 2015 Apr;35(4):1274-89.

  • Blázquez L, Fortes P. U1 snRNP control of 3'-end processing and the therapeutic application of U1 inhibition combined with RNA interference. Curr Mol Med. 2013 Aug;13(7):1203-16. Review.

"We have developed viral vectors that inhibit the expression of target genes by expressing short RNA molecules, and which are very effective in cells in cultures and animal models", Dra. Puri Fortes, Principal Investigator.


Cibeles Pinto
Avda. Pío XII, 55
31008 Pamplona

+34 948 194 700 Ext. 4012